Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

An Innovative Approach to Chemotherapy

March 13th 2023

Positive results have emerged from a trial testing PIPAC, a procedure used for appendiceal, ovarian, gastric and colon cancers that works by spraying chemotherapy directly onto tumors.

Novel Drug to Be Studied in Ovarian Cancer

February 10th 2023

After promising phase 1 results, ART0380 will be studied in a randomized phase 2 trial for patients with platinum-resistant ovarian cancer.

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1st 2023

I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.

Ongoing Trial Shows Positive Response Rates With MEK Inhibitor Combo in Ovarian Cancer Subset

January 30th 2023

Women with low-grade serous ovarian cancer treated with avutometinib and defactinib experienced positive response rates compared with avutometinib alone.

First Patient Dosed with AVB-001 in Trial for Relapsed Refractory Ovarian Cancer

January 19th 2023

The trial is evaluating the safety and efficacy of AVB-001 patients with relapsed refractory ovarian cancer.

Beta-Blockers May Improve Post-Surgical Survival in Women With Ovarian Cancer, Heart Conditions

January 18th 2023

Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.

FDA Approval of Elahere Represents a ‘Step Forward’ for Platinum-Resistant Ovarian Cancer Subset

November 22nd 2022

One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.

I Shouldn’t Have to Pretend ‘Minor’ Side Effects From Cancer Treatment Don’t Bother Me

October 28th 2022

Researchers running clinical should be aware of how these new drugs affect our day-to-day lives — not just in the big ways, but also the small ones that take their toll over the long haul.

Lifestyle Changes and Non-Estrogen-Based Therapies May Alleviate Menopausal Symptoms in Women With Cancer

October 27th 2022

Women who face menopause after a cancer diagnosis may be able to manage their symptoms without relying on estrogen-based therapies, although discussing this with a cancer team will help patients find what’s best for them.

Standup Comedian and Self-Proclaimed 'Love Goddess' Judy Tenuta Dies From Cancer, New England Patriots Host a ‘Day of Pampering’ for Cancer Survivors and More

October 7th 2022

From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.

Early-Phase Trial to Study Novel Drug, With or Without Keytruda, in Solid Cancers

September 27th 2022

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

Phase 3 Trial to Study an Immunochemotherapy Regimen in Platinum-Resistant/Refractory Ovarian Cancer

September 26th 2022

The OnPrime trial will investigate if adding Olvi-Vec, a modified virus, to chemotherapy and Avastin will improve outcomes for pretreated platinum-resistant or refractory ovarian cancer.

Maintenance Therapy the 'Biggest Breakthrough in Decades' for Ovarian Cancer

September 15th 2022

Although maintenance treatments have helped patients with ovarian cancer live longer, experts note there are still some unmet needs that must be addressed.

CAR-T Cell Therapy Shows Promise in Relapsed/Refractory Solid Cancers

September 11th 2022

BNT211-01, a novel CAR-T cell therapy, was efficacious in treating patients with CLDN6-positive, relapsed/refractory solid cancers, according to a small clinical trial.

Rubraca Staves Off Disease Progression Better Than Chemotherapy in BRCA-Mutant Relapsed Ovarian Cancer, Research Shows

September 9th 2022

Rubraca improved progression-free survival in patients with BRCA1/2-mutant, platinum-sensitive, relapsed ovarian cancer, according to findings from the ARIEL4 clinical trial.

Phase 2 Trial to Study Novel Drug in Pretreated Solid Tumors

September 8th 2022

The first patient was treated in a phase 2 trial assessing the safety and efficacy of navicixizumab, with or without chemotherapy, in colorectal, gastric, ovarian and breast cancer.

I’m In a Great Place With My Cancer Despite Feeling 25 Years Older Than I Am

August 19th 2022

I am still here fighting, fighting hard and I will continue to do so to make sure I have more graduations, more weddings, and more everything that I can squeeze into my precious time left here on earth.

Rivoceranib-Based Therapy Improves Outcomes in Recurrent Ovarian Cancer

July 20th 2022

Adding Rivoceranib to pegylated liposomal doxorubicin — a type of chemotherapy — improved survival outcomes for patients with platinum-resistant ovarian cancer, according to recent study results.

To My ‘Cancer Posse,’ Thank You For Everything

July 5th 2022

There are many people in my life who made my cancer experience far easier. I call them my "cancer posse."

Gene Therapy, Gen-1, Shows Promise in Treating Advanced Ovarian Cancer

July 1st 2022

Treatment with Gen-1, a novel gene therapy, resulted in a 33% improvement in progression-free survival for patients with advanced ovarian cancer, according to recent study findings.

FDA Permits the Study of a Novel Cancer Drug for Multiple Solid Tumors to Continue

June 30th 2022

The study the FDA allowed to continue is investigating the safety and efficacy of the novel cancer drug ACR-368 in patients with endometrial, urothelial and ovarian cancer.

Pre- and Post-Surgical Jakafi Plus Chemo Shows Potential in Advanced Ovarian Cancer

June 9th 2022

The use of Jakafi plus chemotherapy shows promise in the pre- and post-surgical treatment settings for patients with stage 3 and 4 ovarian cancer, warranting further study of the combination.

A Behind-the-Scenes Look at My Cancer Clinical Trial Experience

June 1st 2022

It’s good to have all the facts when you decide whether to participate in a cancer drug clinical trial—even the ones that make you swallow hard and tear up.

Investigators Launch Study to Review Novel Cancer Vaccine in Patients With Advanced Solid Tumors

May 26th 2022

A clinical trial just launched to study Vaxinia — a novel cancer vaccine — in patients with previously treated advanced solid tumors.

Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression

May 25th 2022

For patients with advanced epithelial ovarian cancer, there were little — if any — differences in survival outcomes depending on when they received surgery.

'There's a Gift in the Conflict' of Cancer, Says Patrick Dempsey

May 17th 2022

Actor and cancer advocate Patrick Dempsey explains that when a loved one is diagnosed with cancer, it is important that family members make the moments they share together count.

FDA Agrees to Speed Up Review of Ofra-Vec for Platinum-Resistant Ovarian Cancer

April 26th 2022

The FDA granted a Fast Track designation to ofra-vec plus paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

The Return of Spring is a Reminder That the Rough Days of Cancer Will Pass

March 17th 2022

The season of spring represents new awakenings for me, and this year, I’m determined to bring an air of positivity to my life and my cancer experience.

How I Get Through Cancer Survivorship When the Dark Days Take Over

March 8th 2022

While a recent health scare ruined a family vacation, I vowed to keep making plans and always look ahead to brighter days.

New App Aims to Improve the Lives of ‘Core of Our Health Care System’ — Cancer Caregivers

February 28th 2022

When caregivers — considered by many to be an essential part of a patient’s care team — have the tools they need to care for themselves and their loved ones, cancer outcomes can be better, too.